Contrary to conventional wisdom, pursuing massive, hard-to-solve ideas makes it easier to attract capital and top talent. Investors prefer the binary risk-reward of huge outcomes, and the best employees want to work on world-changing problems, not incremental improvements like a new calendar app.

Instead of being a deterrent, having a genuinely hard scientific problem is a powerful recruiting tool. It attracts curious, convention-challenging people who are motivated by solving what others cannot and are willing to work through ambiguity to achieve a breakthrough.

Scientists at Bell Labs who kept their office doors open were interrupted constantly but absorbed more new ideas. While closed-door peers were more productive daily, the open-door scientists solved more significant problems over their careers by working on ideas their counterparts didn't even know existed.

Caltech professor Frances Arnold developed her Nobel-winning "directed evolution" method out of desperation. Realizing her biochemistry knowledge was limited compared to peers using "rational design," she embraced a high-volume, random approach that let the experiment, not her intellect, find the solution.

High achievers are often motivated to solve difficult problems not just for the greater good, but because of the ego-driven satisfaction of accomplishing something few others can. This raw admission reframes ambition as a desire for unique achievement.

Everyone has an unconscious preference for a certain level of problem complexity, which acts as a ceiling. Those who actively choose to take on difficult, multi-faceted problems unlock greatness, while those who prefer 'no problems' remain stagnant.

History shows that major breakthroughs are often preceded by someone who meticulously defines a problem, attracting solvers to it. However, society celebrates the solver, not the definer. Spending more time on precise problem definition is a powerful, yet under-appreciated, path to innovation.

Unlike large pharma where novel projects compete with established, safer alternatives, biotech startups derive immense power from their singular focus. The "live or die" mentality on a single hard problem forces teams to innovate and persevere through setbacks, which is essential for pushing true scientific boundaries.

Solving truly hard problems requires a form of 'arrogance'—an unwavering belief that a solution is possible, even after months or years of failure. This 'can-do' spirit acts as an accelerator, providing the persistence needed to push through challenges where most would give up.